About
David Sinclair is an Australian-American biologist and Professor of Genetics at Harvard Medical School best known for his work on aging biology, epigenetics, NAD metabolism, and longevity interventions. He has co-founded numerous biotechnology and consumer-longevity companies, including Sirtris Pharmaceuticals, Life Biosciences, MetroBiotech, and Tally Health, and publicly discloses investor and equity positions across multiple startups. He is also one of the most visible public advocates and scientific voices in the longevity ecosystem.
Areas of interest
longevityaging biologybiotechepigeneticsgene therapyNAD metabolismconsumer healthdiagnosticsfertilitymetabolismpreventive healthwellness